The Committee for Control and Supervision of Experiments on Animals (CCSEA) has proposed the Draft Animal Testing Rules, 2026, which replicate substantial portions of the European Union Directive 2010/63/EU while omitting the independent authorisation architecture that anchors the European framework. The draft retains exemptions for wild-caught, injured, and stray animals but removes the competent authority’s role in evaluating justifications for such use, creating a structural deficit in regulatory oversight.
How Do The 2026 Draft Rules Undermine The Prevention Of Cruelty To Animals Act?
The draft rules permit in-house Institutional Animal Ethics Committees (IAECs) to classify experiment severity and grant final approval for mild and moderate procedures across all species and purposes. This self-classification mechanism contravenes Section 17(2)(e) of the Prevention of Cruelty to Animals (PCA) Act, which mandates that larger animals be avoided where smaller ones suffice, by reducing the species selection standard to the subjective satisfaction of the approver under Rule 11(6).
Borrowed Text, Missing Architecture
The draft copies definitions for breeder, establishment, project, trader, and user from Article 3 of the EU Directive, alongside the four-tier severity scale and the prohibition on death as an endpoint. However, it excludes Articles 36 to 45, which establish the independent evaluation and authorisation process, and Article 38(2)(c), which requires the competent authority—not the establishment—to assign severity. The definition of “competent authority” under Article 3(7) is also absent, leaving Rules 5(2)(c) and 5(3) without a statutory anchor. The 2006 amendment previously referenced “the authority competent under the law for the time being in force,” a linkage the current draft severs.
Provision Copied into Draft | Provision Omitted from Draft |
|---|---|
Rule 1(4)(d): Evaluation and authorisation of projects (Art. 1(1)(d)) | Articles 36-45: The evaluation and authorisation process itself |
Rule 2 definitions: Breeder, establishment, project, trader, user (Art. 3(2)-(6)) | Article 3(7): Definition of “competent authority” |
Exemptions for wild-caught, injured, stray animals: Rules 5(2)(a), 5(2)(c), 5(3) (Arts. 9(2), 9(3), 11) | Article 38(2)(e): Assessment of justifications in project evaluation; Article 59: Designation of decision-maker |
Death as endpoint: Rule 15(4) (Art. 13(3)) | Article 13(1)-(2): No procedure where recognised alternative exists; use of species with lowest capacity to suffer |
Four-tier severity scale: Rule 7, Annexure-I (Art. 15, Annex VIII) | Article 38(2)(c): Severity assigned by the authority, not the establishment |
Self-Classification and the Approval Vacuum
Under the draft, the establishment classifies each experiment under the severity scale (Rule 7(1)), and the IAEC’s internal veterinarian certifies the classification (Rules 11(10), 16(2)). No schedule records this classification, preventing CCSEA from auditing the label that determines the approval route. Rule 11(3) grants in-house committees final approval over all mild and moderate experiments for every purpose and species, whereas the EU Directive confines in-house bodies to an advisory role under Articles 26 and 27. The simplified procedure under Article 42 of the Directive is optional, excludes primates, and still requires an Article 38 evaluation, offering no remedy for the missing authorisation layer.
Species Selection and Stray Animal Risks
The 2006 amendment required that animals lowest on the phylogenetic scale be considered first (Rule 9(bb)). The draft retains a species test only for protected species and primates under Rules 5(1)(b) and 6(1)(c), omitting the equivalent of EU Directive Article 13(2)(b). For other animals, Schedule III merely asks why a species was chosen, with no standard beyond the approver being “satisfied” under Rule 11(6). Additionally, the stray-animal exemption in Rules 5(2)(c) and 5(3) remains unguarded; a single circular could direct stray dogs from court-sheltered environments into experiments, absent any independent assessment of justification required by Article 38(2)(e) of the Directive.
Gains Offset by Structural Defects
The draft introduces a four-tier severity scale (Rule 7, Annexure-I), a bar on severe, long-lasting pain that cannot be ameliorated (Rule 7(2)), a co-signed euthanasia registry (Rule 15(4)(c)), three-yearly re-registration (Rule 23), and project-specific or immediate sanctions (Rule 25). However, these gains operate within a framework where Rule 13(2)(b) requires projects to run “in accordance with the project authorisation,” which the draft nowhere creates. Each identified defect—the missing competent authority, the self-assigned severity, the diluted species mandate, and the unguarded stray exemption—requires targeted amendment to align the rules with the PCA Act and the commitments expressed in Rule 3(1) regarding non-animal methods.